Form 4: NeuroPace CEO Sells Shares for Tax Obligations

NeuroPace Inc.'s CEO, Joel Becker, disposed of 1,126 shares of common stock on August 27, 2025, to cover tax withholding obligations related to a restricted stock unit award.

Summary

• Joel Becker, Chief Executive Officer and Director of NeuroPace Inc. (NPCE), reported a transaction on August 27, 2025.
• The transaction involved the disposition of 1,126 shares of NeuroPace common stock at a price of $8.88 per share.
• This disposition was made to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit (RSU) award.
• Following this transaction, Mr. Becker directly beneficially owns 104,212 shares of NeuroPace Inc. common stock.
• The transaction was executed pursuant to a Rule 10b5-1(c) plan, indicating it was a pre-arranged sale.

Sentiment

Score: 5

Explanation: The transaction is administrative, related to tax withholding on RSU vesting, and does not reflect a discretionary decision by the insider regarding the company's prospects. Therefore, it is neutral in sentiment.

Positives

• The underlying event, the vesting of a restricted stock unit award, indicates that Mr. Becker met performance or tenure requirements, which is generally a positive for executive compensation.

Negatives

• There are no inherent negatives as the sale was for tax purposes and not a discretionary sale indicating a lack of confidence in the company's future.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This Form 4 filing details a routine insider transaction for tax purposes and does not provide information relevant to broader industry trends or competitive analysis within the medical device or neuroscience sectors.

Comparison to Industry Standards

• Not applicable. This filing reports an individual executive's stock transaction for tax purposes, which is a standard and common practice for executives receiving equity compensation across all industries.

Related Party Transactions

• The transaction involves an executive (Joel Becker) and the company (NeuroPace Inc.) for tax withholding purposes related to equity compensation, which is a common type of transaction between a company and its insiders.

Stakeholder Impact

• Minimal impact on shareholders, as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence.
• No direct impact on employees, customers, suppliers, or creditors is indicated by this administrative filing.

Key Dates

Recommendation

This Form 4 filing reports a routine, non-discretionary sale of shares by the CEO to cover tax obligations upon the vesting of restricted stock units. Such administrative transactions typically do not indicate a change in management's confidence or the company's fundamentals, and therefore do not warrant a change in investment recommendation.

Keywords

NeuroPace, NPCE, Form 4, insider transaction, stock sale, CEO, Joel Becker, tax withholding, RSU, restricted stock unit, executive compensation, 10b5-1 plan